Oxford, AstraZeneca to resume coronavirus vaccine trial

LONDON — Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.

In a statement, the university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.”

It said that globally some 18,000 people have received the vaccine…

Read Full Article

LEAVE A REPLY

Please enter your comment!
Please enter your name here